184 related articles for article (PubMed ID: 34537058)
21. Value and impact factors of multidetector computed tomography in diagnosis of preoperative lymph node metastasis in gastric cancer: A PRISMA-compliant systematic review and meta-analysis.
Luo M; Lv Y; Guo X; Song H; Su G; Chen B
Medicine (Baltimore); 2017 Aug; 96(33):e7769. PubMed ID: 28816957
[TBL] [Abstract][Full Text] [Related]
22. Serum miR-20a is a promising biomarker for gastric cancer.
Yang R; Fu Y; Zeng Y; Xiang M; Yin Y; Li L; Xu H; Zhong J; Zeng X
Biomed Rep; 2017 Apr; 6(4):429-434. PubMed ID: 28413641
[TBL] [Abstract][Full Text] [Related]
23. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
Wu K; Wang L; Fu G; Zheng Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer.
Bai SY; Ji R; Wei H; Guo QH; Yuan H; Chen ZF; Wang YP; Liu Z; Yang XY; Zhou YN
Turk J Gastroenterol; 2019 May; 30(5):415-419. PubMed ID: 31060996
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-20a and miR-486 are potential biomarkers for discriminating colorectal neoplasia: A pilot study.
Yang Q; Wang S; Huang J; Xia C; Jin H; Fan Y
J Cancer Res Ther; 2018; 14(7):1572-1577. PubMed ID: 30589041
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic significance of serum miR-26b and miR-21 expressions in ovarian cancer and their associations with clinicopathological characteristics and prognosis of patients.
Song KW; Zhang QG; Tan WB; Fang YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1697-1703. PubMed ID: 32141536
[TBL] [Abstract][Full Text] [Related]
30. Expression Analysis of mir-21 and mir-221 in Cancerous Tissues from Iranian Patients with Gastric Cancer.
Effatpanah H; Yadegarazari R; Karami M; Majlesi A; Shabab N; Saidijam M
Iran Biomed J; 2015; 19(4):188-93. PubMed ID: 26209976
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
32. Decreased Serum Exosomal microRNA-134 Expression and Its Prognostic Value in Gastric Cancer.
Jin Z; Song Y; Lian C; Gao L
Ann Clin Lab Sci; 2022 Jul; 52(4):563-570. PubMed ID: 36197781
[TBL] [Abstract][Full Text] [Related]
33. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
34. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
36. Relationship between miR-378c and YY1 expression in patients with gastric cancer and the clinicopathological features.
Zhang L; Zou L; Sun P
Cell Mol Biol Lett; 2021 Apr; 26(1):12. PubMed ID: 33794762
[TBL] [Abstract][Full Text] [Related]
37. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
39. Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer.
Wang D; Fan Z; Liu F; Zuo J
Cell Physiol Biochem; 2015; 37(4):1454-62. PubMed ID: 26509997
[TBL] [Abstract][Full Text] [Related]
40. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
